Comparison of the effect of ketamine and magnesium sulfate on acute asthma attack

Comparison of the effect of ketamine nebulizer with magnesium sulfate in the treatment of patients with corticosteroid-resistant asthma referred to the emergency department

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200914048715N1

Enrollment

Registered

2020-09-20

Start date

2020-11-05

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma.

Interventions

Intervention group: and patients will be treated with nebulizerctamine (0.3-0.1 mg / kg). Before and 30 and 60 minutes after treatment with ketamine nebulizer, PEFR was measured by peak flowmeter in t

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: age18 Corticosteroid-resistant asthma attack No history of allergy to ketamine or sulfamide

Exclusion criteria

Exclusion criteria: Dissatisfaction with participating in the study age65 weight>40 Drug or alcohol poisoning Active psychiatric illness History of ketamine allergy

Design outcomes

Primary

Measure	Time frame
Type of treatment - Hospitalization requirement - Acute refractory asthma attack - PEFR. Timepoint: 0-30-60 MIN. Method of measurement: Ketamine protocol - number of patients admitted - peak flowmetry.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmehdi rezari kojani

Karaj University of Medical Sciences

rezaei.mehdi.md@gmail.com+98 26 3457 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026